Are Risk Factors for Growth of Choroidal Nevi Associated With Malignant Transformation? Assessment With a Validated Genomic Biomarker
- 1 January 2019
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 197, 168-179
Abstract
No abstract availableKeywords
Funding Information
- Research to Prevent Blindness
- Melanoma Research Foundation
- Melanoma Research Alliance
- National Cancer Institute (R01 CA125970)
- U.S. Department of War (W81XWH-09-1-0675)
This publication has 58 references indexed in Scilit:
- BAP1 deficiency causes loss of melanocytic cell identity in uveal melanomaBMC Cancer, 2013
- The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal MelanomaPLoS Currents, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Frequent Mutation of BAP1 in Metastasizing Uveal MelanomasScience, 2010
- Mutations inGNA11in Uveal MelanomaNew England Journal of Medicine, 2010
- An Accurate, Clinically Feasible Multi-Gene Expression Assay for Predicting Metastasis in Uveal MelanomaThe Journal of Molecular Diagnostics, 2010
- Reduced expression of autotaxin predicts survival in uveal melanomaBritish Journal of Ophthalmology, 2007
- Fundus autofluorescence of choroidal nevus and melanomaBritish Journal of Ophthalmology, 2007
- Prognostic Testing in Uveal Melanoma by Transcriptomic Profiling of Fine Needle Biopsy SpecimensThe Journal of Molecular Diagnostics, 2006
- Long term ultrasonic follow up of choroidal naevi and their transformation to melanomasBritish Journal of Ophthalmology, 2006